SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a progressive chronic disease associated with severe microvascular and macrovascular complications. Our aim is to assess the real world effectiveness of SGT" inhibitors in achieving metabolic therapeutic goals. METHODS: A retrospective, observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamez-Perez, Héctor Eloy, Delgadillo-Esteban, Enrique, Soni-Duque, David, Hernández-Coria, Mayra Ivonne, Tamez-Peña, Alejandra Lorena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493113/
https://www.ncbi.nlm.nih.gov/pubmed/28680862
http://dx.doi.org/10.1186/s40200-017-0308-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493113/
https://www.ncbi.nlm.nih.gov/pubmed/28680862
http://dx.doi.org/10.1186/s40200-017-0308-4

Ejemplares similares